Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1993 1
1995 1
1996 2
1998 3
1999 2
2000 1
2001 6
2002 5
2003 4
2004 4
2005 9
2006 9
2007 7
2008 18
2009 12
2010 20
2011 16
2012 12
2013 25
2014 19
2015 18
2016 18
2017 17
2018 20
2019 13
2020 9
2021 12
2022 7
2023 12
2024 7
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

273 results

Results by year

Filters applied: . Clear all
Page 1
Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: a randomised controlled, open-label, multicentre trial.
Ponsioen CY, de Groof EJ, Eshuis EJ, Gardenbroek TJ, Bossuyt PMM, Hart A, Warusavitarne J, Buskens CJ, van Bodegraven AA, Brink MA, Consten ECJ, van Wagensveld BA, Rijk MCM, Crolla RMPH, Noomen CG, Houdijk APJ, Mallant RC, Boom M, Marsman WA, Stockmann HB, Mol B, de Groof AJ, Stokkers PC, D'Haens GR, Bemelman WA; LIR!C study group. Ponsioen CY, et al. Among authors: van bodegraven aa. Lancet Gastroenterol Hepatol. 2017 Nov;2(11):785-792. doi: 10.1016/S2468-1253(17)30248-0. Epub 2017 Aug 31. Lancet Gastroenterol Hepatol. 2017. PMID: 28838644 Clinical Trial.
Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: retrospective long-term follow-up of the LIR!C trial.
Stevens TW, Haasnoot ML, D'Haens GR, Buskens CJ, de Groof EJ, Eshuis EJ, Gardenbroek TJ, Mol B, Stokkers PCF, Bemelman WA, Ponsioen CY; LIR!C study group. Stevens TW, et al. Lancet Gastroenterol Hepatol. 2020 Oct;5(10):900-907. doi: 10.1016/S2468-1253(20)30117-5. Epub 2020 Jun 30. Lancet Gastroenterol Hepatol. 2020. PMID: 32619413 Clinical Trial.
Ustekinumab induction and maintenance therapy in refractory Crohn's disease.
Sandborn WJ, Gasink C, Gao LL, Blank MA, Johanns J, Guzzo C, Sands BE, Hanauer SB, Targan S, Rutgeerts P, Ghosh S, de Villiers WJ, Panaccione R, Greenberg G, Schreiber S, Lichtiger S, Feagan BG; CERTIFI Study Group. Sandborn WJ, et al. N Engl J Med. 2012 Oct 18;367(16):1519-28. doi: 10.1056/NEJMoa1203572. N Engl J Med. 2012. PMID: 23075178 Free article. Clinical Trial.
Superior Effectiveness of Tofacitinib Compared to Vedolizumab in Anti-TNF-experienced Ulcerative Colitis Patients: A Nationwide Dutch Registry Study.
Straatmijer T, Biemans VBC, Visschedijk M, Hoentjen F, de Vries A, van Bodegraven AA, Bodelier A, de Boer NKH, Dijkstra G, Festen N, Horjus C, Jansen JM, Jharap B, Mares W, van Schaik FDM, Ponsioen C, Romkens T, Srivastava N, van der Voorn MMPJA, West R, van der Woude J, Wolvers MDJ, Pierik M, van der Meulen-de Jong AE, Duijvestein M; Initiative on Crohn and Colitis. Straatmijer T, et al. Among authors: van bodegraven aa. Clin Gastroenterol Hepatol. 2023 Jan;21(1):182-191.e2. doi: 10.1016/j.cgh.2022.04.038. Epub 2022 May 26. Clin Gastroenterol Hepatol. 2023. PMID: 35644343 Free article.
Clinical nutrition in the hepatogastroenterology curriculum.
Mulder CJ, Wanten GJ, Semrad CE, Jeppesen PB, Kruizenga HM, Wierdsma NJ, Grasman ME, van Bodegraven AA. Mulder CJ, et al. Among authors: van bodegraven aa. World J Gastroenterol. 2016 Feb 7;22(5):1729-35. doi: 10.3748/wjg.v22.i5.1729. World J Gastroenterol. 2016. PMID: 26855532 Free PMC article. Review.
Editorial: nocebo effect and switching to biosimilars.
van Bodegraven AA, Boone NW. van Bodegraven AA, et al. Aliment Pharmacol Ther. 2018 Mar;47(6):850-851. doi: 10.1111/apt.14509. Aliment Pharmacol Ther. 2018. PMID: 29446141 No abstract available.
Dynamic Prediction of Advanced Colorectal Neoplasia in Inflammatory Bowel Disease.
Wijnands AM, Penning de Vries BBL, Lutgens MWMD, Bakhshi Z, Al Bakir I, Beaugerie L, Bernstein CN, Chang-Ho Choi R, Coelho-Prabhu N, Graham TA, Hart AL, Ten Hove JR, Itzkowitz SH, Kirchgesner J, Mooiweer E, Shaffer SR, Shah SC, Elias SG, Oldenburg B; Dutch Initiative on Crohn and Colitis (ICC). Wijnands AM, et al. Clin Gastroenterol Hepatol. 2024 Aug;22(8):1697-1708. doi: 10.1016/j.cgh.2024.02.014. Epub 2024 Feb 29. Clin Gastroenterol Hepatol. 2024. PMID: 38431223 Free article.
COVID-19 in the IBD Population: The Need for Correct Nomenclature.
Rezazadeh Ardabili A, Creemers RH, van Bodegraven AA. Rezazadeh Ardabili A, et al. Among authors: van bodegraven aa. J Crohns Colitis. 2021 May 4;15(5):872-873. doi: 10.1093/ecco-jcc/jjaa222. J Crohns Colitis. 2021. PMID: 33119740 Free PMC article. No abstract available.
Neovaginal discharge in transgender women after vaginoplasty: A diagnostic and treatment algorithm.
van der Sluis WB, de Haseth KB, Elfering L, Özer M, Smit JM, Budding AE, van Bodegraven AA, Buncamper ME, de Boer NKH, Mullender MG, Bouman MB. van der Sluis WB, et al. Among authors: van bodegraven aa. Int J Transgend Health. 2020 Feb 13;21(4):367-372. doi: 10.1080/26895269.2020.1725710. eCollection 2020. Int J Transgend Health. 2020. PMID: 34993515 Free PMC article. No abstract available.
273 results